investing in psychedelics

Mindset Pharma to be Acquired by Otsuka Pharmaceutical

Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) announced that they have entered into a definitive arrangement agreement (the "Agreement") pursuant…

August 31, 2023

Mindset Pharma: Approval for Phase II Clinical Trial, MSP-1014 for Treatment of Major Depressive Disorder

Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) announced that it has received approval from the U.K. Medicines and…

June 22, 2023

Mindset Pharma: New Study Supports Non-Hallucinogenic Psychedelics

Recently, Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) a drug discovery company specializing in next-generation psychedelics, announced the filing of…

June 15, 2023

Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds

Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to…

April 27, 2023